SLB's expectation of flat revenues for 2025, excluding the ChampionX acquisition, highlights concerns about its ability to generate organic growth.
The charms of IBM, EDP Renovaveis, Pfizer, Baker Hughes, Barclays, and others.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback